Sareum Holdings (LSE:SAR) Price-to-Tangible-Book : 58.33 (As of May. 25, 2024)

View and export this data going back to 2004. Start your Free Trial

What is Sareum Holdings Price-to-Tangible-Book?

As of today (2024-05-25), Sareum Holdings's share price is £0.35. Sareum Holdings's Tangible Book per Share of Dec. 2023 for the quarter that ended in Dec. 2023 was £0.01. Hence, Sareum Holdings's Price to Tangible Book Ratio of today is 58.33.

The historical rank and industry rank for Sareum Holdings's Price-to-Tangible-Book or its related term are showing as below:

LSE:SAR' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 3.04 Med: 10.48 Max: 99.17
Current: 35

During the past 13 years, Sareum Holdings's highest Price to Tangible Book Ratio was 99.17. The lowest was 3.04. And the median was 10.48.

LSE:SAR's Price-to-Tangible-Book is ranked worse than
97.54% of 1221 companies
in the Biotechnology industry
Industry Median: 2.79 vs LSE:SAR: 35.00

A closely related ratio is called PB Ratio. As of today, Sareum Holdings's share price is £0.35. Sareum Holdings's Book Value per Sharefor the quarter that ended in Dec. 2023 was £0.01. Hence, Sareum Holdings's P/B Ratio of today is 58.33.

Sareum Holdings Price-to-Tangible-Book Historical Data

The historical data trend for Sareum Holdings's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sareum Holdings Price-to-Tangible-Book Chart

Sareum Holdings Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Price-to-Tangible-Book

Get a 7-Day Free Trial

11.45

9.38

68.45

31.64

73.53

Sareum Holdings Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Price-to-Tangible-Book	Get a 7-Day Free Trial															29.52	31.64	19.64	73.53	99.17

Competitive Comparison of Sareum Holdings's Price-to-Tangible-Book

For the Biotechnology subindustry, Sareum Holdings's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Sareum Holdings's Price-to-Tangible-Book Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Sareum Holdings's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Sareum Holdings's Price-to-Tangible-Book falls into.

Sareum Holdings Price-to-Tangible-Book Calculation

Sareum Holdings's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book	=	Share Price	/	Tangible Book per Share (Q: Dec. 2023 )
	=	0.35	/	0.006
	=	58.33

It can also be calculated from the numbers for the whole company:

Price to Tangible Book	=	Market Cap	/	Tangible Equity
	=	Market Cap	/	(Total Stockholders Equity	-	Preferred Stock	-	Intangible Assets)

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.

Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.

Sareum Holdings Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Sareum Holdings's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.

Sareum Holdings (LSE:SAR) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sareum Holdings PLC (LSE:SAR) » Definitions » Price-to-Tangible-Book

Comparable Companies

Traded in Other Exchanges

RYH0:Germany

Address

Langford Arch, London Road, Unit 2a, Pampisford, Cambridge, Cambridgeshire, GBR, CB22 3FX

Website

http://www.sareum.com

Sareum Holdings PLC is engaged in drug discovery and development. The company is focused on cancer and autoimmune diseases and licensing them to pharmaceutical and biotechnology companies. The company's drug pipeline includes SDC-1801 for autoimmune diseases, SDC-1802 for cancers, SRA737 targeting solid tumors among others.